MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti‐COVID‐19 Therapeutics
Over 313,000 SARS-CoV-2 positive cases have been confirmed in Italy as of 30 September 2020, and the number of deaths exceeding thirty-five thousand makes Italy among the list of most significantly affected countries in the world. Such an enormous occurrence of infections and death raises the urgent...
Main Authors: | Laura Teodori, Piero Sestili, Valeria Madiai, Sofia Coppari, Daniele Fraternale, Marco Bruno Luigi Rocchi, Seeram Ramakrishna, Maria Cristina Albertini |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.582003/full |
Similar Items
-
Microglial Expression of Hdac1 and Hdac2 is Dispensable for Experimental Autoimmune Encephalomyelitis (EAE) Progression
by: Moumita Datta, et al.
Published: (2020-10-01) -
HDAC1 et HDAC2, des rôles redondants et distincts dans la régulation de l'homéostasie intestinale
by: Gonneaud Alexis
Published: (2017) -
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
by: Christian Mayr, et al.
Published: (2021-07-01) -
Hdac1 and Hdac2 are essential for physiological maturation of a Cx3cr1 expressing subset of T-lymphocytes
by: Moumita Datta, et al.
Published: (2021-04-01) -
Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation
by: Vidhi Gaur, et al.
Published: (2016-09-01)